Opportunity
SAM #140D0426Q0306
Sole Source Maintenance and Service Support for Illumina Sequencing Systems at NIH NCI
Buyer
Interior Business Center Acquisition Services Directorate
Posted
April 01, 2026
Respond By
April 08, 2026
Identifier
140D0426Q0306
NAICS
811210, 811219
This opportunity is for maintenance and service support of Illumina sequencing systems at the National Cancer Institute, supporting critical cancer research and patient care. - Sole source procurement to Illumina, Inc., a leading manufacturer of genetic sequencing equipment - Services cover eleven government-owned Illumina sequencing systems and ancillary equipment - Equipment includes NextSeq 2000, NextSeq 550Dx, iScan, and related devices - On-site maintenance services will be performed at NIH NCI facilities in Rockville, MD - Contract features a 12-month base period with one 12-month option period (up to 24 months total) - No other OEMs or vendors are mentioned; Illumina is the exclusive provider - Place of performance is the National Cancer Institute, NIH campus in Rockville, MD - Contracting office is located in Herndon, VA - Estimated contract value likely ranges from $250,000 to $600,000 based on typical service contracts for similar equipment - Requirement is critical for ongoing cancer research and patient care
Key Sections: - OEM: Illumina, Inc. - Equipment: NextSeq 2000, NextSeq 550Dx, iScan, ancillary devices - Services: On-site maintenance and service support - Performance Period: Up to 24 months - Place of Performance: NIH NCI, Rockville, MD - Contracting Office: Herndon, VA - Sole source, no competition specified
Description
Illumina maintenance and service support